OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Prevention of Cardiorenal Complications with Sodium–Glucose Cotransporter Type 2 Inhibitors: A Narrative Review
Manuel Botana, Javier Escalada, Ángel Merchante, et al.
Diabetes Therapy (2022) Vol. 13, Iss. S1, pp. 5-17
Open Access | Times Cited: 6
Manuel Botana, Javier Escalada, Ángel Merchante, et al.
Diabetes Therapy (2022) Vol. 13, Iss. S1, pp. 5-17
Open Access | Times Cited: 6
Showing 6 citing articles:
Cardiovascular and kidney outcomes of combination therapy with sodium-glucose cotransporter-2 inhibitors and mineralocorticoid receptor antagonists in patients with type 2 diabetes and chronic kidney disease: A systematic review and network meta-analysis
Shunichiro Tsukamoto, Ryutaro Morita, Takayuki Yamada, et al.
Diabetes Research and Clinical Practice (2022) Vol. 194, pp. 110161-110161
Closed Access | Times Cited: 21
Shunichiro Tsukamoto, Ryutaro Morita, Takayuki Yamada, et al.
Diabetes Research and Clinical Practice (2022) Vol. 194, pp. 110161-110161
Closed Access | Times Cited: 21
Chronic kidney disease in type 1 diabetes: translation of novel type 2 diabetes therapeutics to individuals with type 1 diabetes
Vikas S. Sridhar, Christine P. Limonte, Per‐Henrik Groop, et al.
Diabetologia (2023) Vol. 67, Iss. 1, pp. 3-18
Closed Access | Times Cited: 11
Vikas S. Sridhar, Christine P. Limonte, Per‐Henrik Groop, et al.
Diabetologia (2023) Vol. 67, Iss. 1, pp. 3-18
Closed Access | Times Cited: 11
GLP-1 receptor agonists and SGLT2 inhibitors: The need to shed light on their safety risks real dimension and possible mechanisms
Fernando Gómez-Peralta, Cristina Abreu, Manfredi Rizzo
Journal of Diabetes and its Complications (2023) Vol. 37, Iss. 8, pp. 108553-108553
Closed Access | Times Cited: 6
Fernando Gómez-Peralta, Cristina Abreu, Manfredi Rizzo
Journal of Diabetes and its Complications (2023) Vol. 37, Iss. 8, pp. 108553-108553
Closed Access | Times Cited: 6
Optimization of cardiovascular risk factor management in patients with BCR::ABL1 negative chronic myeloproliferative neoplasms, current knowledge, and perspectives
Ivan Krečak, Srđan Verstovšek, Marko Lucijanić
Annals of Hematology (2023) Vol. 103, Iss. 5, pp. 1513-1523
Closed Access | Times Cited: 6
Ivan Krečak, Srđan Verstovšek, Marko Lucijanić
Annals of Hematology (2023) Vol. 103, Iss. 5, pp. 1513-1523
Closed Access | Times Cited: 6
WITHDRAWN: SGLT2i reduces renal injury by improving mitochondrial metabolism and biogenesis
Xiaojie Peng, Shuze Chen, Ying Wang, et al.
Molecular Metabolism (2022), pp. 101613-101613
Open Access | Times Cited: 8
Xiaojie Peng, Shuze Chen, Ying Wang, et al.
Molecular Metabolism (2022), pp. 101613-101613
Open Access | Times Cited: 8
Role of Ertugliflozin in the Management of Diabetes Mellitus
Manisha Totade, Shilpa Gaidhane
Cureus (2022)
Open Access | Times Cited: 4
Manisha Totade, Shilpa Gaidhane
Cureus (2022)
Open Access | Times Cited: 4
